Market closed
BiomX Inc./$PHGE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About BiomX Inc.
BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.
Ticker
$PHGE
Sector
Trading on
AMEX
Industry
Biotechnology
Headquarters
Ness Ziona, Israel
Employees
55
Website
BiomX Inc. Metrics
BasicAdvanced
$14M
-
-$3.36
1.39
-
Price and volume
Market cap
$14M
Beta
1.39
52-week high
$0.77
52-week low
$0.48
Average daily volume
157K
Financial strength
Current ratio
2.482
Quick ratio
2.039
Long term debt to equity
35.009
Total debt to equity
39.689
Interest coverage (TTM)
-41.74%
Management effectiveness
Return on assets (TTM)
-65.10%
Return on equity (TTM)
-130.21%
Valuation
Price to book
1.84
Price to tangible book (TTM)
1.84
Price to free cash flow (TTM)
-0.181
Growth
Earnings per share change (TTM)
-34.06%
3-year earnings per share growth (CAGR)
-37.73%
BiomX Inc. News
AllArticlesVideos
BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure
GlobeNewsWire·2 weeks ago
BiomX Announces Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO)
GlobeNewsWire·2 weeks ago
BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for BiomX Inc. stock?
BiomX Inc. (PHGE) has a market cap of $14M as of April 16, 2025.
What is the P/E ratio for BiomX Inc. stock?
The price to earnings (P/E) ratio for BiomX Inc. (PHGE) stock is 0 as of April 16, 2025.
Does BiomX Inc. stock pay dividends?
No, BiomX Inc. (PHGE) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next BiomX Inc. dividend payment date?
BiomX Inc. (PHGE) stock does not pay dividends to its shareholders.
What is the beta indicator for BiomX Inc.?
BiomX Inc. (PHGE) has a beta rating of 1.39. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.